Results from an ongoing malaria vaccine trial show that the risk of malaria is reduced by half in children aged five to 17 months, and for those with severe malaria, who receive the vaccine, the risk is lowered by 47 per cent.

Results from an ongoing malaria vaccine trial show that the risk of malaria is reduced by half in children aged five to 17 months, and for those with severe malaria, who receive the vaccine, the risk is lowered by 47 per cent.

Encouraging  results are revealed from a new vaccine with the scientific name RTS,S whose aim is to trigger the immune system to defend itself against the plasmodium falciparum  malaria parasite by preventing it from infecting, maturing an multiplying in the liver, and from re-

A new report by the World Health Organization says that one third of the 108 countries where malaria was endemic were on course to eradicate the disease within 10 years, with experts further adding that if targets continued to be met, a further three million lives could be saved by 2015.

Preliminary findings of the world most advanced malaria vaccine which was a three year study involving children aged between five and 17 months will be made public tomorrow in Seattle, Washington.

The incidence of malaria in many African countries south of Sahara is rapidly falling. A research group has discovered that the mosquito carrying the malaria parasite has disappeared from villages without any organized mosquito control. Dan Meyrowitsch explains that the99 per cent fall in malaria

Treated mosquito nets are used in Kenya as a way of controlling malaria. However, a study in a Senegalese village showed that mosquitoes are rapidly developing a resistance to the key ingredient used to treat the nets. The research also revealed that nets reduced the immunity of adults and older

The latest Kenya Malaria Indicator Survey shows that malaria prevalence is highest among five to 14 year olds nationwide, with 13 per cent testing positive for malaria by blood smear, and while older children living in endemic areas may have developed immunity against the clinical disease before